The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 21, 2018

Filed:

May. 18, 2015
Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

R. Holland Cheng, Davis, CA (US);

Li Xing, Davis, CA (US);

Chun Chieh Chen, Oakland, CA (US);

Marie Stark, Davis, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/00 (2006.01); C07K 14/005 (2006.01); A61K 9/51 (2006.01);
U.S. Cl.
CPC ...
C07K 14/005 (2013.01); A61K 9/5169 (2013.01); C12N 2770/28122 (2013.01); C12N 2770/28123 (2013.01); C12N 2770/28142 (2013.01);
Abstract

Modified capsid proteins containing at least a portion of hepatitis E virus (HEV) open reading frame 2 (ORF2) having one or more cysteine residues in a surface variable loop or the C-terminus of HEV ORF2, or a portion thereof, are provided. The modified capsid proteins can be used to form hepatitis E virus (HEV) virus like particles (VLPs) having cysteine functional groups exposed on the outer-surface. The exposed cysteine functional groups can be modified via their thiol reactive group. For example, a bioactive agent, such as a cell-targeting ligand, can be conjugated to the one or more cysteines for targeted delivery of chemically activated nanocapsids.


Find Patent Forward Citations

Loading…